Pay in 4 interest-free payments of $6.85 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
This sounds great but there is a catch : the efficacy data from the manufacturer contains only two tests, both in-vitro, aka done in test tubes, not on real people
Brightening and whitening language can mean very different things depending on the ingredient list
increasing flow rate decreases retention times, but also led to interference of placebo components
Research applications In-vitro modeling of synergistic GHRH/GHRP receptor cross-talk Pre-clinical study of pulsatile GH-secretagogue dynamics Comparative receptor-pathway research (cAMP vs calcium convergence) Reference standard for analytical characterization of blended preparations Key facts Combines a GHRH-receptor analog with a selective GHS-R1a agonist Nominal 5mg + 5mg per-component loading per vial Components act through mechanistically independent, convergent pathways Supplied as a co-lyophilized research powder for in-vitro use Product specifications Class: GHRH analog + GHRP/ghrelin-receptor agonist research blend Also known as: Mod-GRF + Ipamorelin blend Form: Lyophilized powder vial Purity: 99% (HPLC verified) Testing: Independent third-party HPLC + mass spectrometry Documentation: Certificate of analysis per batch Storage: Store lyophilized at -20C
Selective Senescent Cell Clearance: The peptide exhibits potent senolytic activity by targeting the FOXO4-p53 axis, a key regulator of cell aging and the aging process
If accidentally left out for more than 4 hours, contact the supervisor
US$ 25.46
US$ 28.47
US$ 22.74